nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial

Denise A. Yardley, Rob Coleman, PierFranco Conte, Javier Cortés, Adam Brufsky, Mikhail Shtivelband, Robyn R. Young, Carmelo Bengala, Haythem Ali, J. Eakel,

Annals of Oncology · 2018 · 133 citations · 20 references

DOIFull text

Open access

Concepts

References

20